Porton Pharma Solutions Ltd. (300363) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Porton Pharma Solutions Ltd.

Why is Porton Pharma Solutions Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 9.52% and Operating profit at -19.53% over the last 5 years

The company has declared Positive results for the last 5 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 686.22 MM
PRE-TAX PROFIT(Q) At CNY 21.48 MM has Grown at 4,370.62%
NET PROFIT(Q) At CNY 27.43 MM has Grown at 855.01%

With ROE of 1.02%, it has a expensive valuation with a 1.24 Price to Book Value

Over the past year, while the stock has generated a return of -1.11%, its profits have risen by 120.6% ; the PEG ratio of the company is 1
At the current price, the company has a high dividend yield of 0.7

Below par performance in long term as well as near term

Along with generating -1.11% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Porton Pharma Solutions Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Porton Pharma Solutions Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Porton Pharma Solutions Ltd.

-9.28%

0.46

52.93%

China Shanghai Composite

8.25%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.52%

EBIT Growth (5y)

-19.53%

EBIT to Interest (avg)

23.55

Debt to EBITDA (avg)

0.35

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.46

Tax Ratio

37.69%

Dividend Payout Ratio

50.65%

Pledged Shares

Institutional Holding

ROCE (avg)

12.86%

ROE (avg)

11.26%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

162

Industry P/E

Price to Book Value

1.64

EV to EBIT

65.81

EV to EBITDA

18.03

EV to Capital Employed

1.64

EV to Sales

2.50

PEG Ratio

1.34

Dividend Yield

0.56%

ROCE (Latest)

2.50%

ROE (Latest)

1.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 686.22 MM

PRE-TAX PROFIT(Q)

At CNY 21.48 MM has Grown at 4,370.62%

NET PROFIT(Q)

At CNY 27.43 MM has Grown at 855.01%

ROCE(HY)

Highest at 2.43%

RAW MATERIAL COST(Y)

Fallen by -37.16% (YoY

-7What is not working for the Company

INTEREST(Q)

At CNY 10.74 MM has Grown at 32.5%

INTEREST COVERAGE RATIO(Q)

Lowest at 270.48

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.83 times

OPERATING PROFIT(Q)

Lowest at CNY 29.04 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 3.28 %

Here's what is working for Porton Pharma Solutions Ltd.

Pre-Tax Profit

At CNY 21.48 MM has Grown at 4,370.62%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 27.43 MM has Grown at 855.01%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 686.22 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost

Fallen by -37.16% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Porton Pharma Solutions Ltd.

Interest

At CNY 10.74 MM has Grown at 32.5%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 270.48

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 29.04 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 3.28 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 2.83 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio